BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s): BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.

CSE:BIOV - Post by User

BioVaxys Technology Corp.

<< Previous

Bullboard Posts

Next >>

Post by moneywagonon Nov 09, 2022 10:34am

55 Views

Post# 35085196

BIOV BOT ITG IS MANIPULATING THE TRADES ON COCAINE

Recent Trades - Last 10 of 163

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
10:09:18	M	0.145	-0.015	20	14 Virtu ITG	14 Virtu ITG
10:07:57	M	0.145	-0.015	50	80 National Bank	80 National Bank
10:07:24	C	0.145	-0.015	500	1 Anonymous	80 National Bank	K
10:07:10	M	0.15	-0.01	200	14 Virtu ITG	14 Virtu ITG
10:06:22	C	0.15	-0.01	300	7 TD Sec	80 National Bank	E
10:06:22	C	0.15	-0.01	1,000	7 TD Sec	1 Anonymous	K
10:05:19	C	0.15	-0.01	3,000	7 TD Sec	1 Anonymous	K
10:03:57	M	0.15	-0.01	115	14 Virtu ITG	14 Virtu ITG
10:00:55	U	0.145	-0.015	2,500	1 Anonymous	1 Anonymous	K
10:00:55	U	0.145	-0.015	2,500	1 Anonymous	1 Anonymous	K